Amyloid-β precursor protein promotes cell proliferation and motility of advanced breast cancer

BMC Cancer

Volumn 14, Issue 1, 2014, Pages

  Lim, Seunghwan ^a   Yoo, Kwon ^b   Kim, Hae Suk ^a   Gilmore, Hannah L ^a   Lee, Yonghun ^a   Lee, Hyun pil ^a   Kim, Seong Jin ^c   Letterio, John ^a,d   Lee, Hyoung Gon ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c CHA University   (South Korea)

^d CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

AKT; Amyloid precursor protein; Apoptosis; Breast cancer; Invasion; p27kip1

Indexed keywords

AMYLOID PRECURSOR PROTEIN; CASPASE 3; FLUOROURACIL; GLYCOGEN SYNTHASE KINASE 3BETA; MESSENGER RNA; PROTEIN KINASE B; PROTEIN P21; PROTEIN P27; RECOMBINANT TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; SHORT HAIRPIN RNA; SOMATOMEDIN C; TRANSCRIPTION FACTOR FKHR; CYCLIN DEPENDENT KINASE INHIBITOR 1B;

ADVANCED CANCER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BREAST CANCER; BREAST CANCER CELL LINE; BREAST CARCINOGENESIS; CANCER GROWTH; CARCINOGENICITY; CELL INVASION; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG SENSITIVITY; G1 PHASE CELL CYCLE CHECKPOINT; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; SIGNAL TRANSDUCTION; TISSUE MICROARRAY; TUMOR XENOGRAFT; WESTERN BLOTTING; ANIMAL; BREAST TUMOR; CANCER STAGING; CELL MOTION; DISEASE MODEL; DRUG SCREENING; FEMALE; GENETICS; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; APOPTOSIS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; CYCLIN-DEPENDENT KINASE INHIBITOR P27; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION; GENE KNOCKDOWN TECHNIQUES; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MICE; NEOPLASM STAGING; PROTO-ONCOGENE PROTEINS C-AKT; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84924369281     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-14-928     Document Type: Article

References (51)

1. O'Brien RJ, Wong PC: Amyloid precursor protein processing and Alzheimer's disease. Annu Rev Neurosci 2011, 34:185-204. 10.1146/annurev-neuro-061010-113613
2. Hardy JA, Higgins GA: Alzheimer's disease: the amyloid cascade hypothesis. Science 1992,256(5054):184-185. 10.1126/science.1566067
3. De Strooper B, Annaert W: Proteolytic processing and cell biological functions of the amyloid precursor protein. J Cell Sci 2000,113(Pt 11):1857-1870.
4. Jacobsen KT, Iverfeldt K: Amyloid precursor protein and its homologues: a family of proteolysis-dependent receptors. Cell Mol Life Sci 2009,66(14):2299-2318. 10.1007/s00018-009-0020-8
5. Sheng B, Song B, Zheng Z, Zhou F, Lu G, Zhao N, Zhang X, Gong Y: Abnormal cleavage of APP impairs its functions in cell adhesion and migration. Neurosci Lett 2009,450(3):327-331. 10.1016/j.neulet.2008.11.046
6. Sosa LJ, Bergman J, Estrada-Bernal A, Glorioso TJ, Kittelson JM, Pfenninger KH: Amyloid precursor protein is an autonomous growth cone adhesion molecule engaged in contact guidance. PLoS One 2013,8(5):e64521. 10.1371/journal.pone.0064521
7. Baratchi S, Evans J, Tate WP, Abraham WC, Connor B: Secreted amyloid precursor proteins promote proliferation and glial differentiation of adult hippocampal neural progenitor cells. Hippocampus 2012,22(7):1517-1527. 10.1002/hipo.20988
8. Hoffmann J, Twiesselmann C, Kummer MP, Romagnoli P, Herzog V: A possible role for the Alzheimer amyloid precursor protein in the regulation of epidermal basal cell proliferation. Eur J Cell Biol 2000,79(12):905-914. 10.1078/0171-9335-00117
9. Pietrzik CU, Hoffmann J, Stober K, Chen CY, Bauer C, Otero DA, Roch JM, Herzog V: From differentiation to proliferation: the secretory amyloid precursor protein as a local mediator of growth in thyroid epithelial cells. Proc Natl Acad Sci U S A 1998,95(4):1770-1775. 10.1073/pnas.95.4.1770
10. Meng JY, Kataoka H, Itoh H, Koono M: Amyloid beta protein precursor is involved in the growth of human colon carcinoma cell in vitro and in vivo. Int J Cancer 2001,92(1):31-39. 10.1002/1097-0215(200102)9999:9999<::AID-IJC1155>3.0.CO;2-H
11. Hansel DE, Rahman A, Wehner S, Herzog V, Yeo CJ, Maitra A: Increased expression and processing of the Alzheimer amyloid precursor protein in pancreatic cancer may influence cellular proliferation. Cancer Res 2003,63(21):7032-7037.
12. Krause K, Karger S, Sheu SY, Aigner T, Kursawe R, Gimm O, Schmid KW, Dralle H, Fuhrer D: Evidence for a role of the amyloid precursor protein in thyroid carcinogenesis. J Endocrinol 2008,198(2):291-299. 10.1677/JOE-08-0005
13. Takayama K, Tsutsumi S, Suzuki T, Horie-Inoue K, Ikeda K, Kaneshiro K, Fujimura T, Kumagai J, Urano T, Sakaki Y, Shirahige K, Sasano H, Takahashi S, Kitamura T, Ouchi Y, Aburatani H, Inoue S: Amyloid precursor protein is a primary androgen target gene that promotes prostate cancer growth. Cancer Res 2009,69(1):137-142. 10.1158/0008-5472.CAN-08-3633
14. Venkataramani V, Rossner C, Iffland L, Schweyer S, Tamboli IY, Walter J, Wirths O, Bayer TA: Histone deacetylase inhibitor valproic acid inhibits cancer cell proliferation via down-regulation of the alzheimer amyloid precursor protein. J Biol Chem 2010,285(14):10678-10689. 10.1074/jbc. M109.057836
15. Takagi K, Ito S, Miyazaki T, Miki Y, Shibahara Y, Ishida T, Watanabe M, Inoue S, Sasano H, Suzuki T: Amyloid precursor protein (APP) in human breast cancer: an androgen-induced gene associated with cell proliferation. Cancer Sci 2013,104(11):1532-1538. 10.1111/cas.12239
16. Young-Pearse TL, Bai J, Chang R, Zheng JB, LoTurco JJ, Selkoe DJ: A critical function for beta-amyloid precursor protein in neuronal migration revealed by in utero RNA interference. J Neurosci 2007,27(52):14459-14469. 10.1523/JNEUROSCI.4701-07.2007
17. Young-Pearse TL, Chen AC, Chang R, Marquez C, Selkoe DJ: Secreted APP regulates the function of full-length APP in neurite outgrowth through interaction with integrin beta1. Neural Dev 2008, 3:15. 10.1186/1749-8104-3-15
18. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D: Global cancer statistics. Cancer J Clin 2011,61(2):69-90. 10.3322/caac.20107
19. Hong S, Lim S, Li AG, Lee C, Lee YS, Lee EK, Park SH, Wang XJ, Kim SJ: Smad7 binds to the adaptors TAB2 and TAB3 to block recruitment of the kinase TAK1 to the adaptor TRAF2. Nat Immunol 2007,8(5):504-513. 10.1038/ni1451
20. Harris JA, Devidze N, Verret L, Ho K, Halabisky B, Thwin MT, Kim D, Hamto P, Lo I, Yu GQ, Palop JJ, Masliah E, Mucke L: Transsynaptic progression of amyloid-beta-induced neuronal dysfunction within the entorhinal-hippocampal network. Neuron 2010,68(3):428-441. 10.1016/j.neuron.2010.10.020
21. Minn AJ, Gupta GP, Siegel PM, Bos PD, Shu W, Giri DD, Viale A, Olshen AB, Gerald WL, Massague J: Genes that mediate breast cancer metastasis to lung. Nature 2005,436(7050):518-524. 10.1038/nature03799
22. Tang B, Vu M, Booker T, Santner SJ, Miller FR, Anver MR, Wakefield LM: TGF-beta switches from tumor suppressor to prometastatic factor in a model of breast cancer progression. J Clin Invest 2003,112(7):1116-1124. 10.1172/JCI200318899
23. Miller FR, Soule HD, Tait L, Pauley RJ, Wolman SR, Dawson PJ, Heppner GH: Xenograft model of progressive human proliferative breast disease. J Natl Cancer Inst 1993,85(21):1725-1732. 10.1093/jnci/85.21.1725
24. Aslakson CJ, Miller FR: Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor. Cancer Res 1992,52(6):1399-1405.
25. Mattson MP: Cellular actions of beta-amyloid precursor protein and its soluble and fibrillogenic derivatives. Physiol Rev 1997,77(4):1081-1132.
26. Kummer C, Wehner S, Quast T, Werner S, Herzog V: Expression and potential function of beta-amyloid precursor proteins during cutaneous wound repair. Exp Cell Res 2002,280(2):222-232. 10.1006/excr.2002.5631
27. Sherr CJ, Roberts JM: CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev 1999,13(12):1501-1512. 10.1101/gad.13.12.1501
28. Caldon CE, Daly RJ, Sutherland RL, Musgrove EA: Cell cycle control in breast cancer cells. J Cell Biochem 2006,97(2):261-274. 10.1002/jcb.20690
29. Chu IM, Hengst L, Slingerland JM: The Cdk inhibitor p27 in human cancer: prognostic potential and relevance to anticancer therapy. Nat Rev 2008,8(4):253-267. 10.1038/nrc2347
30. Wander SA, Zhao D, Slingerland JM: p27: a barometer of signaling deregulation and potential predictor of response to targeted therapies. Clin Cancer Res 2011,17(1):12-18. 10.1158/1078-0432.CCR-10-0752
31. Mahalingam D, Szegezdi E, Keane M, de Jong S, Samali A: TRAIL receptor signalling and modulation: Are we on the right TRAIL? Cancer Treat Rev 2009,35(3):280-288. 10.1016/j.ctrv.2008.11.006
32. Joensuu H, Gligorov J: Adjuvant treatments for triple-negative breast cancers. Ann Oncol 2012,23(Suppl 6):vi40-vi45.
33. Lee GY, Kenny PA, Lee EH, Bissell MJ: Three-dimensional culture models of normal and malignant breast epithelial cells. Nat Methods 2007,4(4):359-365. 10.1038/nmeth1015
34. Schmeichel KL, Bissell MJ: Modeling tissue-specific signaling and organ function in three dimensions. J Cell Sci 2003,116(Pt 12):2377-2388.
35. Weigelt B, Bissell MJ: Unraveling the microenvironmental influences on the normal mammary gland and breast cancer. Semin Cancer Biol 2008,18(5):311-321. 10.1016/j.semcancer.2008.03.013
36. Kenny PA, Lee GY, Myers CA, Neve RM, Semeiks JR, Spellman PT, Lorenz K, Lee EH, Barcellos-Hoff MH, Petersen OW, Gray JW, Bissell MJ: The morphologies of breast cancer cell lines in three-dimensional assays correlate with their profiles of gene expression. Mol Oncol 2007,1(1):84-96. 10.1016/j.semcancer.2008.03.013
37. Hollestelle A, Elstrodt F, Nagel JH, Kallemeijn WW, Schutte M: Phosphatidylinositol-3-OH kinase or RAS pathway mutations in human breast cancer cell lines. Mol Cancer Res 2007,5(2):195-201. 10.1158/1541-7786.MCR-06-0263
38. Chakrabarty A, Bhola NE, Sutton C, Ghosh R, Kuba MG, Dave B, Chang JC, Arteaga CL: Trastuzumab-resistant cells rely on a HER2-PI3K-FoxO-survivin axis and are sensitive to PI3K inhibitors. Cancer Res 2013,73(3):1190-1200. 10.1158/0008-5472.CAN-12-2440
39. Rexer BN, Arteaga CL: Optimal targeting of HER2-PI3K signaling in breast cancer: mechanistic insights and clinical implications. Cancer Res 2013,73(13):3817-3820. 10.1158/0008-5472.CAN-13-0687
40. Tzivion G, Dobson M, Ramakrishnan G: FoxO transcription factors; Regulation by AKT and 14-3-3 proteins. Biochim Biophys Acta 2011,1813(11):1938-1945. 10.1016/j.bbamcr.2011.06.002
41. Clarke RB: p27KIP1 phosphorylation by PKB/Akt leads to poor breast cancer prognosis. Breast Cancer Res 2003,5(3):162-163. 10.1186/bcr596
42. Zheng H, Jiang M, Trumbauer ME, Hopkins R, Sirinathsinghji DJ, Stevens KA, Conner MW, Slunt HH, Sisodia SS, Chen HY, Van der Ploeg LH: Mice deficient for the amyloid precursor protein gene. Ann N Y Acad Sci 1996, 777:421-426. 10.1111/j.1749-6632.1996.tb34456.x
43. Goodarzi H, Zhang S, Buss CG, Fish L, Tavazoie S, Tavazoie SF: Metastasis-suppressor transcript destabilization through TARBP2 binding of mRNA hairpins. Nature 2014,513(7517):256-260. 10.1038/nature13466
44. King TD, Suto MJ, Li Y: The Wnt/beta-catenin signaling pathway: a potential therapeutic target in the treatment of triple negative breast cancer. J Cell Biochem 2012,113(1):13-18. 10.1002/jcb.23350
45. Incassati A, Chandramouli A, Eelkema R, Cowin P: Key signaling nodes in mammary gland development and cancer: beta-catenin. Breast Cancer Res 2010,12(6):213. 10.1186/bcr2723
46. Yang JY, Hung MC: Deciphering the role of forkhead transcription factors in cancer therapy. Curr Drug Targets 2011,12(9):1284-1290. 10.2174/138945011796150299
47. Srinivasula SM, Ashwell JD: IAPs: what's in a name? Mol Cell 2008,30(2):123-135. 10.1016/j.molcel.2008.03.008
48. Jimenez S, Torres M, Vizuete M, Sanchez-Varo R, Sanchez-Mejias E, Trujillo-Estrada L, Carmona-Cuenca I, Caballero C, Ruano D, Gutierrez A, Vitorica J: Age-dependent accumulation of soluble amyloid beta (Abeta) oligomers reverses the neuroprotective effect of soluble amyloid precursor protein-alpha (sAPP(alpha)) by modulating phosphatidylinositol 3-kinase (PI3K)/Akt-GSK-3beta pathway in Alzheimer mouse model. J Biol Chem 2011,286(21):18414-18425. 10.1074/jbc. M110.209718
49. Larue L, Bellacosa A: Epithelial-mesenchymal transition in development and cancer: role of phosphatidylinositol 3'kinase/AKT pathways. Oncogene 2005,24(50):7443-7454. 10.1038/sj.onc.1209091
50. Gilles C, Polette M, Mestdagt M, Nawrocki-Raby B, Ruggeri P, Birembaut P, Foidart JM: Transactivation of vimentin by beta-catenin in human breast cancer cells. Cancer Res 2003,63(10):2658-2664.
51. Roxanis I: Occurrence and significance of epithelial-mesenchymal transition in breast cancer. J Clin Pathol 2013,66(6):517-521. 10.1136/jclinpath-2012-201348